Cargando…
Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
For almost half a century, cardiac transplant has been the only long-term treatment for patients with end-stage heart failure. Implantable left ventricular assist devices (LVADs) have emerged as a new treatment option for advanced heart failure as destination therapy for patients either too old or n...
Autores principales: | Bayes-Genis, Antoni, Muñoz-Guijosa, Christian, Santiago-Vacas, Evelyn, Montero, Santiago, García-García, Cosme, Codina, Pau, Núñez, Julio, Lupón, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215475/ https://www.ncbi.nlm.nih.gov/pubmed/32419850 http://dx.doi.org/10.15420/ecr.2019.29.2 |
Ejemplares similares
-
Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020) -
Gender-Related Differences in Heart Failure Biomarkers
por: Cediel, Germán, et al.
Publicado: (2021) -
Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022) -
Assessment of right ventricular function by echocardiography in patients with chronic heart failure
por: William, Viola, et al.
Publicado: (2018) -
Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
por: Lupón, Josep, et al.
Publicado: (2021)